输注野生型巨噬细胞在Hmox1缺陷小鼠肝脏定植并自我更新以挽救溶血和贫血
本研究向Hmox1敲除小鼠输注野生型巨噬细胞,发现其可在肝脏定植并增殖,纠正小细胞性贫血、挽救血管内溶血、恢复铁稳态、消除肾脏铁过载和组织损伤,并提供长期保护。结果表明单次巨噬细胞输注可产生长期治愈效果,无需骨髓移植。
要点
- 野生型巨噬细胞在Hmox1敲除小鼠肝脏定植并增殖。
- 单次输注纠正小细胞性贫血、挽救血管内溶血、恢复铁稳态。
- 单次输注消除肾脏铁过载和组织损伤并提供长期保护。
核心结论
- 单次野生型巨噬细胞输注在Hmox1敲除小鼠中产生长期治愈效果,无需骨髓移植。
- HMOX1疾病主要源于有活力的网状内皮巨噬细胞缺失。
- 输注野生型巨噬细胞有潜力预防HMOX1缺陷患者及其他巨噬细胞相关疾病。
研究设计与样本
- 向Hmox1敲除小鼠输注野生型巨噬细胞的体内研究。
主要发现
- 野生型巨噬细胞在Hmox1敲除小鼠肝脏定植并增殖。
- 纠正小细胞性贫血、挽救血管内溶血、恢复铁稳态。
- 消除肾脏铁过载和组织损伤并提供长期保护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heme oxygenase 1 (HMOX1), the inducible enzyme that catabolizes the degradation of heme into biliverdin, iron, and carbon monoxide, plays an essential role in the clearance of senescent and damaged red blood cells, systemic iron homeostasis, erythropoiesis, vascular hemostasis, and oxidative and inflammatory stress responses. In humans, HMOX1 deficiency causes a rare and lethal disease, characterized by severe anemia, intravascular hemolysis, as well as vascular and tissue damage. Hmox1 knockout (KO) mice recapitulated the phenotypes of HMOX1-deficiency patients and could be rescued by bone marrow (BM) transplantation that engrafted donor's hematopoietic stem cells into the recipient animals after myeloablation. To find better therapy and elucidate the contribution of macrophages to the pathogenesis of HMOX1-deficiency disease, we infused wild-type (WT) macrophages into Hmox1 KO mice. Results showed that WT macrophages engrafted and proliferated in the livers of Hmox1 KO mice, which corrected the microcytic anemia, rescued the intravascular hemolysis, restored iron homeostasis, eliminated kidney iron overload and tissue damage, and provided long-term protection. These results showed that a single macrophage infusion delivered a long-term curative effect in Hmox1 KO mice, obviating the need for BM transplantation, and suggested that the HMOX1 disease stems mainly from the loss of viable reticuloendothelial macrophages. Our work provides new insights into the etiology of HMOX1 deficiency and demonstrates the potential of infusion of WT macrophages to prevent disease in patients with HMOX1 deficiency and potentially other macrophage-related diseases.
引用
- Kim KS, Zhang DL, Kovtunovych G, et al. Infused wild-type macrophages reside and self-renew in the liver to rescue the hemolysis and anemia of Hmox1-deficient mice. Blood Adv. 2018. PMID: 30337301. doi:10.1182/bloodadvances.2018019737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。